219 related articles for article (PubMed ID: 14602237)
1. Exosomes bearing HLA-G are released by melanoma cells.
Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
[TBL] [Abstract][Full Text] [Related]
2. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
3. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.
Chang CC; Murphy SP; Ferrone S
Hum Immunol; 2003 Nov; 64(11):1057-63. PubMed ID: 14602236
[TBL] [Abstract][Full Text] [Related]
4. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
[TBL] [Abstract][Full Text] [Related]
7. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
9. Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line.
Riteau B; Moreau P; Menier C; Khalil-Daher I; Khosrotehrani K; Bras-Goncalves R; Paul P; Dausset J; Rouas-Freiss N; Carosella ED
Transplant Proc; 2001 May; 33(3):2360-4. PubMed ID: 11377559
[No Abstract] [Full Text] [Related]
10. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment.
Frumento G; Franchello S; Palmisano GL; Nicotra MR; Giacomini P; Loke YW; Geraghty DE; Maio M; Manzo C; Natali PG; Ferrara GB
Tissue Antigens; 2000 Jul; 56(1):30-7. PubMed ID: 10958353
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
12. HLA-G promotes immune tolerance.
Rouas-Freiss N; Paul P; Dausset J; Carosella ED
J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
[TBL] [Abstract][Full Text] [Related]
13. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
14. HLA-G in skin cancer: a wolf in sheep's clothing?
Urosevic M; Dummer R
Hum Immunol; 2003 Nov; 64(11):1073-80. PubMed ID: 14602238
[TBL] [Abstract][Full Text] [Related]
15. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
[TBL] [Abstract][Full Text] [Related]
16. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
[TBL] [Abstract][Full Text] [Related]
17. Intestinal epithelial cells secrete exosome-like vesicles.
van Niel G; Raposo G; Candalh C; Boussac M; Hershberg R; Cerf-Bensussan N; Heyman M
Gastroenterology; 2001 Aug; 121(2):337-49. PubMed ID: 11487543
[TBL] [Abstract][Full Text] [Related]
18. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
19. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
20. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Sangrouber D; Marcou C; Le Discorde M; Chang CC; Carosella ED; Moreau P
J Immunol Methods; 2007 Sep; 326(1-2):54-62. PubMed ID: 17689555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]